Evaluating the Effectiveness of Colon Preparation for Endoscopy Using Specialized Clinical Nutrition

April 11, 2017 updated by: Nutricia Advanced

Phase IV Prospective Sinle Center Randomised Three-arm Controlled Study Evaluating the Effectiveness of Colon Preparation for Endoscopy Using Specialized Clinical Nutrition

This study is an open, prospective, comparative diagnostic studies aimed at improving the colonoscopy results, by optimizing the way of preparation for endoscopy

Study Overview

Detailed Description

Objective: to improve the quality of bowel preparation for endoscopy.

Research objectives:

  1. Compare the three methods of colon preparation for endoscopy
  2. To develop a rational strategy of preparing patients for endoscopy on the basis of the data obtained.

Study Type

Interventional

Enrollment (Actual)

150

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Moscow, Russian Federation, 123103
        • ГНЦ колопроктологии

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Patients older than 18 years with the recommendation to conduct a diagnostic colonoscopy
  2. Absence of contraindications to the use of specialized clinical nutrition products

Exclusion Criteria:

  1. Conditions which are contraindicated for colonoscopy:

    • The acute phase of cerebrovascular accident
    • Acute myocardial infarction
    • severe cardiovascular, pulmonary insufficiency and mixed
    • Violations of the cardiac rhythm (paroxysmal bradyarrhythmia, atrial fibrillation with atrial fibrillation or paroxysmal atrial fibrillation, severe transverse heart block)
    • Severe clinical forms (fulminant) inflammatory diseases of the colon (ulcerative colitis, Crohn's disease, ischemic colitis, radiation colitis, diverticulitis)
    • Aortic aneurysm or heart
    • Acute inflammatory infiltrates abdominal cavity (including diverticulitis)
    • Suspicion of abscess of the abdominal cavity
    • Peritonitis
    • Hepatosplenomegaly
    • Tense ascites
    • hydrothorax, hydropericardium
    • Severe blood coagulation
    • Hemorrhagic vasculitis
  2. Pregnancy
  3. The patient's refusal to participate in the study
  4. Intolerance of specialized clinical nutrition products

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Group Nutridrink 200ml
50 patients: two days before the investigation is assigned to a diet with the use of specialized clinical nutrition Nutridrink 200 ml 6 bottles per day as a sole source of nutrition. On the day of the colonoscopy, as breakfast, allowed Nutridrink 1-2 bottles
Nutridrink 200 ml 6 bottles per day as a sole source of nutrition. On the day of the colonoscopy, as breakfast, allowed Nutridrink 1-2 bottles
Active Comparator: Group Nutridrink compact protein
two days before the study is assigned diet with the addition of specialized clinical nutrition Nutridrinc compact protein 125 ml 2 bottles per day. On the day of the colonoscopy, as breakfast, allowed Nutridrink compact protein 1-2 bottles
2 bottles per day. On the day of the colonoscopy, as breakfast, allowed Nutridrink compact protein 1-2 bottles
No Intervention: Group control
only diet without receiving specialized nutrition

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
the degree of preparation in the colonoscopy (Chicago or Boston scale).
Time Frame: before colonoscopy
before colonoscopy

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
tolerability
Time Frame: before colonoscopy
Visual analog scale assessment of tolerability of the preparation to the study
before colonoscopy

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Elena Volkova

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2016

Primary Completion (Actual)

September 1, 2016

Study Completion (Actual)

November 1, 2016

Study Registration Dates

First Submitted

March 16, 2016

First Submitted That Met QC Criteria

March 16, 2016

First Posted (Estimate)

March 21, 2016

Study Record Updates

Last Update Posted (Actual)

April 13, 2017

Last Update Submitted That Met QC Criteria

April 11, 2017

Last Verified

April 1, 2017

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Colonoscopy

Clinical Trials on Nutridrink 200 ml

3
Subscribe